Erythropoietic protoporphyrias: updates and advances

Area of Science:

• Biochemistry
• Genetics
• Dermatology

Background:

• Protoporphyrias stem from genetic mutations affecting heme biosynthesis enzymes.
• This leads to the buildup of protoporphyrin (PPIX), a phototoxic compound, in red blood cells.
• Accumulated PPIX causes severe, painful photosensitivity and increases the risk of liver disease.

Purpose of the Study:

• To review the pathophysiology, diagnosis, and current management of protoporphyrias.
• To discuss emerging therapeutic strategies for this rare genetic disorder.

Main Methods:

• Literature review of protoporphyrias.
• Analysis of current treatment guidelines.
• Overview of ongoing clinical trials for novel therapies.

Main Results:

• Pathophysiology involves enzyme deficiencies in heme synthesis pathway.
• Diagnosis relies on clinical presentation and biochemical testing.
• Current care is largely supportive, focusing on light avoidance.

Conclusions:

• Protoporphyrias present significant challenges due to photosensitivity and liver disease risk.
• Novel therapeutic strategies are under investigation and show promise for future treatment.
• These advancements may significantly improve outcomes for patients with protoporphyrias.